The efficacy of a tart cherry drink for the treatment of patellofemoral pain in recreationally active individuals: a placebo randomized control trial

Abstract Purpose This study aimed to explore the efficacy of U.S. Montmorency tart cherry in treating recreationally active individuals with patellofemoral pain. Methods Twenty-four participants pain were randomly separated into either placebo (males N = 8, females 4, age 43.30 ± 7.86 yrs, mass 72.10 17.89 kg, stature 171.16 10.17, BMI 24.31 3.75 kg/m 2 , symptom duration 30.18 10.90) or 9, 3, 41.75 7.52 76.96 16.64 173.05 7.63, 25.53 4.03 29.73 11.88) groups. Both groups ingested 60 mL concentrate taste matched daily for 6 weeks. Measures self-reported (KOOS-PF), psychological wellbeing (COOP WONCA), and sleep quality (PSQI) alongside blood biomarkers (C-reactive protein, uric acid, TNF alpha, creatinine, total antioxidant capacity) knee biomechanics quantified at baseline Differences between examined using linear mixed-effects models. Results There was 1 withdrawal 0 group no adverse events noted condition. The condition exhibited significant improvements (baseline 67.90 16.18 & weeks 78.04 14.83) KOOS-PF scores compared 67.28 12.55& 67.55 20.61). No other statistically observations observed. Conclusion Tart supplementation as specifically current investigation does not appear be effective mediating symptoms individuals.